comparemela.com

Latest Breaking News On - Steadymed ltd - Page 1 : comparemela.com

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 - AND - MANAGEMENT INFORMATION CIRCULAR .

University of daytonUnited statesNew jerseyUnited kingdomNew yorkPrinceton universitySanofi pasteurAngela holthamLaurel hillBroadridge quickvoteDeborahm brownThomasc heinemanJamest parsonsAptose biosciencesMatthewc coffeyAmyg levin

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 9, 2023 - AND - MANAGEMENT INFORMATION CIRCULAR . | April 6, 2023

United statesUnited kingdomNew yorkNew jerseyPrinceton universityUniversity of daytonLeonard kruimerMatt coffeyBristol myers squibbThomasc heinemanJonathan rigbyAllison hagermanDeborah brownMichael bennettWayne pisanoDeborahm brown

Oncolytics Biotech Inc : Oncolytics Biotech Appoints Jonathan Rigby to its Board of Directors

Mr. Rigby is the Group Chief Executive Officer of Revolo Biotherapeutics and has three decades of experience in the pharmaceutical and biotechnology industries SAN DIEGO and CALGARY, AB

United kingdomMatt coffeyJonathan rigbyJon pattonRevolo biotherapeuticsTimothy mccarthyOncolytics biotech incUnited therapeutics corporationCompany contactSheffield universityZogenix incPortsmouth universitySteadymed ltdSecurities exchangeBristol myers squibbHonors in biological sciences

Oncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors

/PRNewswire/ Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the appointment of Jonathan Rigby to its Board of Directors. "Jonathan has.

United kingdomMatt coffeyJonathan rigbyJon pattonRevolo biotherapeuticsTimothy mccarthyOncolytics biotech incUnited therapeutics corporationCompany contactSheffield universityZogenix incPortsmouth universitySteadymed ltdOncolytics biotechSecurities exchangeBristol myers squibb

Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesJason adairLiquidia technologies incYork heart associationUnited therapeutics corporationDrug administrationUs district courtSteadymed ltdLiquidia corporationCorporate developmentHatch waxman actChief executive officerPatent trialAppeal boardOrange bookNew drug application

vimarsana © 2020. All Rights Reserved.